Literature DB >> 1932738

Absence of the human retinoblastoma gene product in the megakaryoblastic crisis of chronic myelogenous leukemia.

M Towatari1, K Adachi, H Kato, H Saito.   

Abstract

The human retinoblastoma gene (RB) product, which is involved in the control of cell cycle and tumor suppression, is constitutively expressed as a nuclear phosphoprotein in normal human cells. We examined leukemic cells from 22 patients with blast crisis of chronic myelogenous leukemia (CML) for alterations of the RB expression. Western blotting and flow cytometry with anti-RB-protein antibodies showed that all of five cases with megakaryoblastic crisis lacked the expression of the RB-encoded protein, whereas none of 17 cases with the other phenotypes such as myeloblastic or lymphoblastic crisis showed any abnormality. These findings suggest that megakaryoblastic transformation of CML might be lineage-specifically associated with loss of the RB protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932738

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  Targeting the leukemic stem cell: the Holy Grail of leukemia therapy.

Authors:  N Misaghian; G Ligresti; L S Steelman; F E Bertrand; J Bäsecke; M Libra; F Nicoletti; F Stivala; M Milella; A Tafuri; M Cervello; A M Martelli; J A McCubrey
Journal:  Leukemia       Date:  2008-09-18       Impact factor: 11.528

2.  Mouse models as tools to understand and study BCR-ABL1 diseases.

Authors:  Steffen Koschmieder; Mirle Schemionek
Journal:  Am J Blood Res       Date:  2011-06-07

Review 3.  Src kinase signaling in leukaemia.

Authors:  Shaoguang Li
Journal:  Int J Biochem Cell Biol       Date:  2007-02-09       Impact factor: 5.085

Review 4.  Molecular biology of chronic myeloid leukemia.

Authors:  Y Maru
Journal:  Int J Hematol       Date:  2001-04       Impact factor: 2.490

5.  Targeting multiple kinase pathways in leukemic progenitors and stem cells is essential for improved treatment of Ph+ leukemia in mice.

Authors:  Yiguo Hu; Sarah Swerdlow; Theodore M Duffy; Roberto Weinmann; Francis Y Lee; Shaoguang Li
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-31       Impact factor: 11.205

6.  The tsA58 simian virus 40 large tumor antigen disrupts megakaryocyte differentiation in transgenic mice.

Authors:  M O Robinson; W Zhou; M Hokom; D M Danilenko; R Y Hsu; R E Atherton; W Xu; S Mu; C J Saris; S Swift
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

7.  The BCR-ABL oncoprotein potentially interacts with the xeroderma pigmentosum group B protein.

Authors:  N Takeda; M Shibuya; Y Maru
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-05       Impact factor: 11.205

8.  Genetic analysis of p53 and RB1 tumor-suppressor genes in blast crisis of chronic myeloid leukemia.

Authors:  G Gaidano; A Serra; A Guerrasio; G Rege-Cambrin; U Mazza; G Saglio
Journal:  Ann Hematol       Date:  1994-01       Impact factor: 3.673

9.  Signaling by ABL oncogenes through cyclin D1.

Authors:  D E Afar; J McLaughlin; C J Sherr; O N Witte; M F Roussel
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

10.  A mutation in the Icsbp1 gene causes susceptibility to infection and a chronic myeloid leukemia-like syndrome in BXH-2 mice.

Authors:  Karine Turcotte; Susan Gauthier; Ashleigh Tuite; Alaka Mullick; Danielle Malo; Philippe Gros
Journal:  J Exp Med       Date:  2005-03-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.